Guanidino-containing drugs in cancer chemotherapy: biochemical and clinical pharmacology33Abbreviations: MIBG, m-iodobenzylguanidine; MGBG, methylglyoxal bis(guanylhydrazone); MIBA, m-iodobenzylamine; BG, benzylguanidine; NE, norepinephrine; GBG, glyoxal bis(guanylhydrazone); EGBG, ethylglyoxal bis(guanylhydrazone); MGBCP, methylglyoxal bis(cyclopentylamidinohydrazone); ODC, ornithine decarboxylase; and SAMDC, S-adenosylmethionine decarboxylase.

2001/05/01 by Sara Ekelund, Peter Nygren, Rolf Larsson · 4 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · Medicine · #Amino Acid Enzymes and Metabolism #Biochemistry #Cancer #Cancer research #Cancer, Hypoxia, and Metabolism #Chemistry #Chemotherapy #Cisplatin #Cytotoxic T cell #Enzyme #In vitro #Internal medicine #Medicine #Methylglyoxal #Pharmacology #Polyamine #Polyamine Metabolism and Applications #Spermidine

paper · doi:10.1016/s0006-2952(01)00570-6

openalex publication_date 2001/05/01 · openalex created_date 2016/06/24 · openalex updated_date 2026/07/26

Citations

• Mitochondrial effects of the guanidino group-containing cytostatic drugs, m-iodobenzylguanidine and methylglyoxal bis (guanylhydrazone)

Cited by

• Solid-phase synthesis of a library of amphipatic hydantoins. Discovery of new hits for TRPV1 blockade. [europepmc]
• A model of modified meta -iodobenzylguanidine conjugated gold nanoparticles for neuroblastoma treatment. [europepmc]
• Guanylation Reactions for the Rational Design of Cancer Therapeutic Agents. [europepmc]
• Aryl Guanyl Hydrazones: A Viable Strategy for Designing BBB-Permeable, Neuroactive Compounds? [europepmc]